Miettinen, Markku
National Cancer Institute (NCI),
United States
2024 Rank: 784
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3 out of 24457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 784 | 888 |
| Total Cites | 46293 | 48935 |
| H-index | 108 | 110 |
| Hm-index | 58 | 60 |
| Number of Single Authored Papers | 66 | 66 |
| Total Cites to Single Authored Papers | 1314 | 1387 |
| Number of Single+First Authored Papers | 202 | 202 |
| Total Cites to Single+First Authored Papers | 21766 | 22533 |
| Number of Single+First+Last Authored Papers | 361 | 361 |
| Total Cites to Single+First+Last Authored Papers | 33677 | 35235 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 27418 | 28470 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.72 |
| Self-Citation Percentage |
5.40%
|
|
Miettinen, Markku
National Cancer Institute (NCI),
United States
2023 Rank: 727
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3 out of 23576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 727 | 830 |
| Total Cites | 44198 | 46736 |
| H-index | 105 | 108 |
| Hm-index | 57 | 59 |
| Number of Single Authored Papers | 66 | 66 |
| Total Cites to Single Authored Papers | 1274 | 1347 |
| Number of Single+First Authored Papers | 202 | 202 |
| Total Cites to Single+First Authored Papers | 20893 | 21649 |
| Number of Single+First+Last Authored Papers | 361 | 361 |
| Total Cites to Single+First+Last Authored Papers | 32321 | 33857 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 25857 | 26841 |
| Ratio of Total Citations to Distinct Citing Papers | 1.71 | 1.74 |
| Self-Citation Percentage |
5.43%
|
|
Miettinen, Markku
National Cancer Institute (NCI),
United States
2022 Rank: 751
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 4 out of 23010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 751 | 863 |
| Total Cites | 40359 | 42786 |
| H-index | 99 | 103 |
| Hm-index | 55 | 56 |
| Number of Single Authored Papers | 66 | 66 |
| Total Cites to Single Authored Papers | 1195 | 1268 |
| Number of Single+First Authored Papers | 201 | 201 |
| Total Cites to Single+First Authored Papers | 19374 | 20121 |
| Number of Single+First+Last Authored Papers | 355 | 355 |
| Total Cites to Single+First+Last Authored Papers | 29667 | 31173 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 23524 | 24439 |
| Ratio of Total Citations to Distinct Citing Papers | 1.72 | 1.75 |
| Self-Citation Percentage |
5.67%
|
|
Miettinen, Markku
National Cancer Institute (NCI),
United States
2021 Rank: 733
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 4 out of 22656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 733 | 859 |
| Total Cites | 39152 | 41492 |
| H-index | 97 | 100 |
| Hm-index | 54 | 55 |
| Number of Single Authored Papers | 66 | 66 |
| Total Cites to Single Authored Papers | 1157 | 1230 |
| Number of Single+First Authored Papers | 200 | 200 |
| Total Cites to Single+First Authored Papers | 18697 | 19420 |
| Number of Single+First+Last Authored Papers | 355 | 355 |
| Total Cites to Single+First+Last Authored Papers | 28931 | 30406 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 22876 | 23757 |
| Ratio of Total Citations to Distinct Citing Papers | 1.71 | 1.75 |
| Self-Citation Percentage |
5.64%
|
|
Miettinen, Markku
National Cancer Institute,
United States
2020 Rank: 710
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3 out of 19713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 710 | 785 |
| Total Cites | 36378 | 38595 |
| H-index | 94 | 98 |
| Hm-index | 51 | 53 |
| Number of Single Authored Papers | 66 | 66 |
| Total Cites to Single Authored Papers | 1106 | 1178 |
| Number of Single+First Authored Papers | 201 | 201 |
| Total Cites to Single+First Authored Papers | 17576 | 18290 |
| Number of Single+First+Last Authored Papers | 351 | 351 |
| Total Cites to Single+First+Last Authored Papers | 27174 | 28624 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 21015 | 21818 |
| Ratio of Total Citations to Distinct Citing Papers | 1.73 | 1.77 |
| Self-Citation Percentage |
5.74%
|
|